CAMP and asthma: Moreover, the patterns of cathelicidin levels in asthma (decreased in a stable state) and COPD (increased in a stable state of GOLD I and II) allows us to hypothesize that LL-37 could serve as a biomarker for distinguishing between these two diseases [31,43,57,58].